These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 2319465)

  • 1. The antiseizure activity of dihydropyridine calcium channel antagonists in the conscious rat.
    Morón MA; Stevens CW; Yaksh TL
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1150-5. PubMed ID: 2319465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diltiazem enhances and flunarizine inhibits nimodipine's antiseizure effects.
    Morón MA; Stevens CW; Yaksh TL
    Eur J Pharmacol; 1989 Apr; 163(2-3):299-307. PubMed ID: 2721577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
    Zahradníková A; Minarovic I; Zahradník I
    J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identical inhibitory modulation of A-type potassium currents by dihydropyridine calcium channel agonists and antagonists.
    Mlinar B; Enyeart JJ
    Mol Pharmacol; 1994 Oct; 46(4):743-9. PubMed ID: 7969054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
    Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.
    Yamaguchi S; Zhorov BS; Yoshioka K; Nagao T; Ichijo H; Adachi-Akahane S
    Mol Pharmacol; 2003 Aug; 64(2):235-48. PubMed ID: 12869628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship study of 1,4-dihydropyridine derivatives blocking N-type calcium channels.
    Yamamoto T; Niwa S; Ohno S; Onishi T; Matsueda H; Koganei H; Uneyama H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Shoji M
    Bioorg Med Chem Lett; 2006 Feb; 16(4):798-802. PubMed ID: 16309909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure-activity relationship study on 2-, 5-, and 6-position of the water soluble 1,4-dihydropyridine derivatives blocking N-type calcium channels.
    Yamamoto T; Niwa S; Ohno S; Tokumasu M; Masuzawa Y; Nakanishi C; Nakajo A; Onishi T; Koganei H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Shoji M
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4813-6. PubMed ID: 18684623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effect of trimethylamine on the anticonvulsant activities of quinine in the pentylenetetrazole model in rats.
    Nassiri-Asl M; Zamansoltani F; Zangivand AA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1496-500. PubMed ID: 18556104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nifedipine inhibits picrotoxin-induced seizure activity: further evidence on the involvement of L-type calcium channel blockers in epilepsy.
    Otoom S; Hasan Z
    Fundam Clin Pharmacol; 2006 Apr; 20(2):115-9. PubMed ID: 16573711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimemorfan prevents seizures induced by the L-type calcium channel activator BAY k-8644 in mice.
    Shin EJ; Nabeshima T; Lee PH; Kim WK; Ko KH; Jhoo JH; Jhoo WK; Cha JY; Kim HC
    Behav Brain Res; 2004 May; 151(1-2):267-76. PubMed ID: 15084442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 1,4-dihydropyridine receptor: a regulatory component of the Ca2+ channel.
    Triggle DJ; Janis RA
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S949-55. PubMed ID: 6085383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dihydropyridine nitrendipine modulates N-methyl-D-aspartate receptor channel function in mammalian neurons.
    Skeen GA; Twyman RE; White HS
    Mol Pharmacol; 1993 Aug; 44(2):443-50. PubMed ID: 8394997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
    Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
    J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric interactions required for high-affinity binding of dihydropyridine antagonists to Ca(V)1.1 Channels are modulated by calcium in the pore.
    Peterson BZ; Catterall WA
    Mol Pharmacol; 2006 Aug; 70(2):667-75. PubMed ID: 16675661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for L-type calcium channels in the maturation of parvalbumin-containing hippocampal interneurons.
    Jiang M; Swann JW
    Neuroscience; 2005; 135(3):839-50. PubMed ID: 16154277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel high affinity class of Ca2+ channel blockers.
    Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
    Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectivity of the protective effects of dihydropyridine calcium channel antagonists against the ethanol withdrawal syndrome.
    Watson WP; Little HJ
    Brain Res; 2002 Mar; 930(1-2):111-22. PubMed ID: 11879801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification by dihydropyridine-type calcium antagonists of the renal hemodynamic response to vasoconstrictors.
    Loutzenhiser R; Epstein M; Horton C
    J Cardiovasc Pharmacol; 1987; 9 Suppl 1():S70-5. PubMed ID: 2441189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.